TABLE 2.
Continent of acquisition of erythromycin-, tetracycline-, and ciprofloxacin-resistant (multidrug-resistant) C. jejuni subsp. jejuni and C. coli isolates from Montreal, Quebec, Canada, 2002 to 2013
| Continent of isolate acquisitiona | No. of C. jejuni subsp. jejuni and C. coli isolates | No. (%) of multidrug-resistant C. jejuni subsp. jejuni and C. coli isolatesb |
|---|---|---|
| The Americas | 63 | 10 (15.9) |
| Europe | 24 | 2 (8.3) |
| Asia | 31 | 1 (3.2) |
| Africa | 49 | 0 (0) |
| Total | 167 | 13 |
a
No C. jejuni subsp. jejuni/C. coli isolates were acquired from Oceania. The continent of acquisition was unknown for 2 C. jejuni subsp. jejuni/C. coli isolates.
b
P = 0.013.